raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:231183

Usher syndrome type 3

Synonyms: USH3

Type
Clinical subtype
Group
Subtype of disorder
Inheritance
Autosomal recessive
Age of onset
Adolescent, Childhood
Status
active

A rare ciliopathy characterized by progressive hearing and visual loss in the first decades of life and, in some cases, vestibular dysfunction. Patients have normal hearing at birth. Onset of hearing loss is usually in late childhood or adolescence after development of speech. Profound deafness is mostly reported by middle age. Retinitis pigmentosa related visual loss also develops in late childhood or adolescence. Developmental motor milestones are generally normal but vestibular dysfunction may occur in adulthood.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enUsher syndrome type 3USH3
frSyndrome d'Usher type 3= en
deUsher-Syndrom Typ 3= en
esSíndrome de Usher tipo 3= en
itSindrome di Usher tipo 3= en
nlSyndroom van Usher type 3= en
ptSíndrome de Usher tipo 3
plZespół Ushera typu 3= en
csUsherův syndrom, typ III= en
ukСиндром Ашера, тип 3= en
zhUsher综合征3型= en
trUsher sendromu tip 3= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM276902BTNTvalidated
OMIM500004BTNTvalidated
OMIM614504BTNTvalidated
OMIM617236BTNTvalidated
ICD-10H35.5NTBTattributedvalidated
ICD-11LD2H.4NTBTindexvalidated
MONDO0016485Evalidated
UMLSC1568248Evalidated
GARD5442Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

  • ORPHA:886Usher syndrome
    rare developmental anomalies during embryogenesis; rare genetic diseases; rare ophthalmic disorders; rare otorhinolaryngological diseases

No children.

4

Genes

5 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
ARSGDisease-causing germline mutation(s) inAssessedHGNC:24102ENSG0000014133761000817q24.2arylsulfatase G29300381[PMID]
CEP78Disease-causing germline mutation(s) inAssessedHGNC:25740ENSG000001480196171109q21.2centrosomal protein 7827627988[PMID]
CLRN1Disease-causing germline mutation(s) inAssessedHGNC:12605ENSG000001636466063973q25.1clarin 119753315[PMID]
HARS1Disease-causing germline mutation(s) inAssessedHGNC:4816ENSG000001704451428105q31.3histidyl-tRNA synthetase 122279524[PMID]
MT-TS2Disease-causing germline mutation(s) inNot yet assessedHGNC:7498ENSG00000210184590085mitochondriamitochondrially encoded tRNA-Ser (AGU/C) 2
5

Prevalence and incidence

3 records
TypeClassValueAreaQualificationValidationSource
Point prevalence1-9 / 1 000 0000.1 / 100 000DenmarkValue and classValidated9212179[PMID]
Point prevalence1-9 / 1 000 000—EuropeClass onlyNot yet validatedORPHANET
Point prevalence1-9 / 100 0001.2 / 100 000Specific populationValue and classValidated14569126[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

12 annotations · validated 2025-09-08
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0000375Abnormal cochlea morphology
HP:0000512Abnormal electroretinogram
HP:0007730Iris hypopigmentation
HP:0000662Nyctalopia
HP:0000510Rod-cone dystrophy
HP:0000575Scotoma
HP:0000407Sensorineural hearing impairment
HP:0001756Vestibular hypofunction
HP:0000572Visual loss
Occasional (29-5%)
HP:0001751Abnormal vestibular function
HP:0000739Anxiety
HP:0000716Depression

Run the differential on the 9 obligate / very frequent terms

Annotation source: 39304915[PMID]_30974196[PMID]

7

Sources for this card